Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan Free

Abstract

The antiviral activity against dengue virus-2 (DENV-2) of carrageenans reported here has shown a differential susceptibility of C6/36 HT and Vero cells, taken as models of mosquito and mammalian cells, depending on the structural class of polysaccharides: all polysaccharides blocked DENV-2 infection in monkey Vero cells, but only iota-carrageenans were virus inhibitors in mosquito cells. However, iota-carrageenans were less effective in mosquito cells in comparison with mammalian cells with effective concentration 50 % (EC) values in C6/36 HT cells 4.9–17.5-fold higher than in Vero cells, as determined by virus yield reduction assay. The mode of action of iota-carrageenan in both cell types was strikingly different: in Vero cells the inhibitory activity was exerted only at the initiation of the cycle, affecting virion binding, whereas in mosquito cells DENV-2 adsorption was not affected and comparable levels of inhibition were obtained if the compound was added to cells together with the virus, after 8 h of infection or by cell pre-treatment before infection. Furthermore, iota-carrageenans induced a subtle alteration in mosquito cells, detected by cell proliferation and protein synthesis analyses, suggesting that a probable cellular target may be responsible for the refractory state of mosquito cells to DENV-2 infection produced by this class of polysulfates. The failure of iota-carrageenan to block DENV-2 adsorption to mosquito cells appeared to be related to the low presence of adequate heparan sulfate (HS) in C6/36 HT cell surface and is indicative of a differential participation of HS residues for DENV-2 entry in both types of cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.028522-0
2011-06-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/6/1332.html?itemId=/content/journal/jgv/10.1099/vir.0.028522-0&mimeType=html&fmt=ahah

References

  1. Avirutnan P., Zhang L., Punyadee N., Manuyakorn A., Puttikhunt C., Kasinrerk W., Malasit P., Atkinson J. P., Diamond M. S. 2007; Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog 3:e183 [View Article][PubMed]
    [Google Scholar]
  2. Baeuerle P. A., Huttner W. B. 1986; Chlorate–a potent inhibitor of protein sulfation in intact cells. Biochem Biophys Res Commun 141:870–877 [View Article][PubMed]
    [Google Scholar]
  3. Barth H., Schnober E. K., Zhang F., Linhardt R. J., Depla E., Boson B., Cosset F. L., Patel A. H., Blum H. E., Baumert T. F. 2006; Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol 80:10579–10590 [View Article][PubMed]
    [Google Scholar]
  4. Bishop J. R., Schuksz M., Esko J. D. 2007; Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446:1030–1037 [View Article][PubMed]
    [Google Scholar]
  5. Buck C. B., Thompson C. D., Roberts J. N., Müller M., Lowy D. R., Schiller J. T. 2006; Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog 2:e69 [View Article][PubMed]
    [Google Scholar]
  6. Chee H. Y., AbuBakar S. 2004; Identification of a 48kDa tubulin or tubulin-like C6/36 mosquito cells protein that binds dengue virus 2 using mass spectrometry. Biochem Biophys Res Commun 320:11–17 [View Article][PubMed]
    [Google Scholar]
  7. Chen Y., Maguire T., Hileman R. E., Fromm J. R., Esko J. D., Linhardt R. J., Marks R. M. 1997; Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3:866–871 [View Article][PubMed]
    [Google Scholar]
  8. Damonte E. B., Matulewicz M. C., Cerezo A. S. 2004; Sulfated seaweed polysaccharides as antiviral agents. Curr Med Chem 11:2399–2419[PubMed] [CrossRef]
    [Google Scholar]
  9. de S.F-Tischer P. C., Talarico L. B., Noseda M. D., Guimaraes S. M. P. B., Damonte E. B., Duarte M. E. R. 2006; Chemical structure and antiviral activity of carrageenans from Meristiella gelidium against herpes simplex and dengue virus. Carbohydr Polym 63:459–465 [View Article]
    [Google Scholar]
  10. Esko J. D., Selleck S. B. 2002; Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435–471 [View Article][PubMed]
    [Google Scholar]
  11. Germi R., Crance J. M., Garin D., Guimet J., Lortat-Jacob H., Ruigrok R. W., Zarski J. P., Drouet E. 2002; Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292:162–168 [View Article][PubMed]
    [Google Scholar]
  12. Gubler D. J. 2002; Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10:100–103 [View Article][PubMed]
    [Google Scholar]
  13. Hidari K. I., Takahashi N., Arihara M., Nagaoka M., Morita K., Suzuki T. 2008; Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem Biophys Res Commun 376:91–95 [View Article][PubMed]
    [Google Scholar]
  14. Hilgard P., Stockert R. 2000; Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology 32:1069–1077 [View Article][PubMed]
    [Google Scholar]
  15. Hung S. L., Lee P. L., Chen H. W., Chen L. K., Kao C. L., King C. C. 1999; Analysis of the steps involved in Dengue virus entry into host cells. Virology 257:156–167 [View Article][PubMed]
    [Google Scholar]
  16. Hung J. J., Hsieh M. T., Young M. J., Kao C. L., King C. C., Chang W. 2004; An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol 78:378–388 [View Article][PubMed]
    [Google Scholar]
  17. Kuadkitkan A., Wikan N., Fongsaran C., Smith D. R. 2010; Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells. Virology 406:149–161 [View Article][PubMed]
    [Google Scholar]
  18. Lee E., Pavy M., Young N., Freeman C., Lobigs M. 2006; Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res 69:31–38 [View Article][PubMed]
    [Google Scholar]
  19. Lin Y. L., Lei H. Y., Lin Y. S., Yeh T. M., Chen S. H., Liu H. S. 2002; Heparin inhibits dengue-2 virus infection of five human liver cell lines. Antiviral Res 56:93–96 [View Article][PubMed]
    [Google Scholar]
  20. Marks R. M., Lu H., Sundaresan R., Toida T., Suzuki A., Imanari T., Hernáiz M. J., Linhardt R. J. 2001; Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors. J Med Chem 44:2178–2187 [View Article][PubMed]
    [Google Scholar]
  21. Martínez-Barragán J. J., del Angel R. M. 2001; Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection. J Virol 75:7818–7827 [View Article][PubMed]
    [Google Scholar]
  22. Ono L., Wollinger W., Rocco I. M., Coimbra T. L., Gorin P. A., Sierakowski M. R. 2003; In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain). Antiviral Res 60:201–208 [View Article][PubMed]
    [Google Scholar]
  23. Paingankar M. S., Gokhale M. D., Deobagkar D. N. 2010; Dengue-2-virus-interacting polypeptides involved in mosquito cell infection. Arch Virol 155:1453–1461 [View Article][PubMed]
    [Google Scholar]
  24. Pujol C. A., Estevez J. M., Carlucci M. J., Ciancia M., Cerezo A. S., Damonte E. B. 2002; Novel DL-galactan hybrids from the red seaweed Gymnogongrus torulosus are potent inhibitors of herpes simplex virus and dengue virus. Antivir Chem Chemother 13:83–89[PubMed] [CrossRef]
    [Google Scholar]
  25. Qiu H., Tang W., Tong X., Ding K., Zuo J. 2007; Structure elucidation and sulfated derivatives preparation of two α-d-glucans from Gastrodia elata Bl. and their anti-dengue virus bioactivities. Carbohydr Res 342:2230–2236 [View Article][PubMed]
    [Google Scholar]
  26. Rostand K. S., Esko J. D. 1997; Microbial adherence to and invasion through proteoglycans. Infect Immun 65:1–8[PubMed]
    [Google Scholar]
  27. Salas-Benito J., Reyes-Del Valle J., Salas-Benito M., Ceballos-Olvera I., Mosso C., del Angel R. M. 2007; Evidence that the 45-kD glycoprotein, part of a putative dengue virus receptor complex in the mosquito cell line C6/36, is a heat-shock related protein. Am J Trop Med Hyg 77:283–290[PubMed]
    [Google Scholar]
  28. Sessions O. M., Barrows N. J., Souza-Neto J. A., Robinson T. J., Hershey C. L., Rodgers M. A., Ramirez J. L., Dimopoulos G., Yang P. L. et al. 2009; Discovery of insect and human dengue virus host factors. Nature 458:1047–1050 [View Article][PubMed]
    [Google Scholar]
  29. Sinnis P., Coppi A., Toida T., Toyoda H., Kinoshita-Toyoda A., Xie J., Kemp M. M., Linhardt R. J. 2007; Mosquito heparan sulfate and its potential role in malaria infection and transmission. J Biol Chem 282:25376–25384 [View Article][PubMed]
    [Google Scholar]
  30. Spillmann D. 2001; Heparan sulfate: anchor for viral intruders?. Biochimie 83:811–817 [View Article][PubMed]
    [Google Scholar]
  31. Talarico L. B., Damonte E. B. 2007; Interference in dengue virus adsorption and uncoating by carrageenans. Virology 363:473–485 [View Article][PubMed]
    [Google Scholar]
  32. Talarico L. B., Pujol C. A., Zibetti R. G., Faría P. C., Noseda M. D., Duarte M. E., Damonte E. B. 2005; The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Res 66:103–110 [View Article][PubMed]
    [Google Scholar]
  33. Talarico L. B., Duarte M. E., Zibetti R. G., Noseda M. D., Damonte E. B. 2007; An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection. Planta Med 73:1464–1468 [View Article][PubMed]
    [Google Scholar]
  34. Thaisomboonsuk B. K., Clayson E. T., Pantuwatana S., Vaughn D. W., Endy T. P. 2005; Characterization of dengue-2 virus binding to surfaces of mammalian and insect cells. Am J Trop Med Hyg 72:375–383[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.028522-0
Loading
/content/journal/jgv/10.1099/vir.0.028522-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed